|
Corporate Social Responsibility
News
12.01.2007 - 10:47pm ET
|
CSR News from:
|
|
|
News Categories: |
| | |
The Magic Johnson Foundation and Abbott Expand Focus Of 'Campaign To End Black AIDS' to African-American Women in 2008
Cookie Johnson, Wife of Earvin "Magic" Johnson, Will Educate African-American Women on the Importance of HIV/AIDS Prevention, Testing and Treatment
(CSRwire) NEW YORK, NY -November 30, 2007 - In conjunction with World AIDS Day,
Earvin "Magic" Johnson, the Magic Johnson Foundation and Abbott today
announced that Cookie Johnson, wife of Earvin "Magic" Johnson will be
touring throughout the country in 2008 to educate women on HIV/AIDS.
Earvin "Magic" Johnson will continue to be the primary ambassador for the
"I Stand With Magic" program to inform people about the disease, encourage
people to get tested and if necessary, seek treatment for HIV if they are
HIV positive. The program also will be traveling to New York, Los Angeles
and Chicago to provide free HIV testing and education in recognition of
World AIDS Day 2007.
Since its 2006 launch, the "I Stand With Magic" program, a part of the
"Campaign to End Black AIDS," has provided free HIV/AIDS testing to more
than 21,000 Americans in 16 major cities with large African-American
populations as part of the "I Stand With Magic" tour. Additionally, the
program has educated nearly 200,000 people about HIV, risk factors
associated with the disease, the importance of HIV testing and how to care
for yourself or someone you know living with the disease. More than 70,000
individuals have enrolled in the program in order to receive regular
newsletters and communication from Magic Johnson about how to stay
informed about the disease. Anyone who is personally impacted by HIV, is
a caretaker of someone who is HIV positive or just wants to support the
cause can enroll on the program’s Web site, www.istandwithmagic.com.
According to the Center for Disease Control (CDC), in 2005, approximately
half of the nearly 40,000 new HIV/AIDS diagnoses in the United States
occurred among African Americans, who represented just 13 percent of the
general population. The impact of HIV/AIDS on African-American women has
been particularly concerning. HIV/AIDS is the leading cause of death for
African-American women 25-34 years old. In 2005, the AIDS diagnosis rate
for African-American women was approximately 23 times the rate for
Caucasian women. Further, this minority population accounts for 66
percent of new HIV/AIDS cases among all women.
Cookie Johnson, the wife of Earvin "Magic" Johnson, is now touring the
country with the "I Stand With Magic" program to educate minority women
about HIV/AIDS and provide tools for prevention and testing. Cookie
prides herself on being the first to "stand" with Magic. In addition to
Cookie, the program is extending an invitation to other prominent
African-American leaders to join the campaign.
"When we first learned about Earvin's diagnosis we bonded together as a
family to arm ourselves with education on HIV/AIDS," said Cookie. "I was
determined that we would fight this disease together as a family. As the
newest 'I Stand With Magic' program ambassador, I will encourage women in
minority communities in America to get educated, tested and treated for
HIV/AIDS throughout the next year. Today, I want to share what we learned
about HIV/AIDS with others, especially women who might be going through a
similar situation as my own."
In celebration of World AIDS Day, Abbott and the Magic Johnson Foundation
are also hosting concerts with musicians including Angie Stone, Erykah
Badu, Mary Mary and the Soul Seekers, who will perform and encourage
people to get informed, get tested and seek treatment if necessary.
"Educating minority communities about HIV/AIDS and encouraging them to get
tested and seek treatment is crucial to helping prevent HIV in the
African-American community," said Earvin "Magic" Johnson. "I am thrilled
that many prominent leaders in the African-American community are standing
with me to help in this effort, and I hope together we can access all of
our networks and call on our friends to lower the number of new infections
caused by this devastating epidemic."
"At Abbott, we are proud of our partnership with the Magic Johnson
Foundation and our accomplishments in addressing this public health
crisis, but we recognize that significant work remains," said Mary Szela,
senior vice president, Pharmaceutical Operations, Abbott. "We have set
our sights on reaching even more people in 2008 and will continue to help
combat this epidemic in minority populations."
To learn more about the "I Stand with Magic Program and Campaign to End
Black AIDS" or to join the program, visit www.istandwithmagic.com.
About "I Stand with Magic"
Through the "I Stand with Magic" program, Abbott and the Magic Johnson
Foundation are joining forces to address the alarming rate of HIV/AIDS in
the African-American community by aiming to reduce the new HIV infection
rate in half over five years. Through this partnership, Earvin "Magic"
Johnson and Abbott hold educational activities and testing events in
cities with high HIV infection rates. In 2006, the initiative embarked
on a 10-city tour of high schools and counseling centers across the nation
to provide HIV testing, education and additional resources for HIV-positive
individuals. In 2007, the campaign has visited almost 200 churches, high
schools and colleges. For more information and to "stand with Magic" in
the fight against HIV/AIDS, visit www.istandwithmagic.com.
About the Magic Johnson Foundation
The Magic Johnson Foundation was established in 1991 as a single-disease
organization that works to raise funds for community-based organizations
dealing with HIV/AIDS education and prevention programs. The Foundation
has since responded to the growing need to address all aspects of our
youth's lives by expanding its mission. This expanded mission emphasizes
the Foundation's focus on supporting community-based organizations and
development programs that serve the health, educational and social needs
of those residing in minority communities.
About Abbott
Abbott has been a leader in HIV/AIDS research since the early years of the
epidemic. In 1985, the company developed the first licensed test to detect
HIV antibodies in the blood and remains a leader in HIV diagnostics.
Abbott retroviral and hepatitis tests are used to screen more than half of
the world's donated blood supply. Abbott has developed two protease
inhibitors for the treatment of HIV.
Expanding on its scientific contributions, Abbott and Abbott Fund have
invested more than $100 million in developing countries to improve the
lives of people affected by HIV/AIDS through programs targeting critical
areas of need, including strengthening health care systems, supporting
children affected by HIV/AIDS, and advancing HIV testing and treatment.
For more information on Abbott's HIV/AIDS programs, please visit www.abbott.com/HIVAIDS and www.abbottglobalcare.org.
Abbott is a global, broad-based health care company devoted to the
discovery, development, manufacture and marketing of pharmaceuticals and
medical products, including nutritionals, devices and diagnostics. The
company employs 65,000 people and markets its products in more than 130
countries.
Abbott's news releases and other information are available on the
company's Web site at www.abbott.com.
|
|